• Health / Pharma

Esperer Bioresearch strengthens its senior leadership team Announces appointment of Dhruv Arora as Global Business Head

• Prashant Kapadia
• September 11, 2019

by Prashant Kapadia/NHN

Mumbai, September, 2019: Esperer Bioresearch Pvt. Ltd, one of India’s first nutritional companies for cancer patients today inducts industry veteran Dhruv Ashish Arora as their Global Business Head. Having more than 17 years of experience in Healthcare, Banking and Market Research industry, Dhruv Arora has worked across geographies on a variety of transactions such business model restructuring, stake holder networking, relationship management and market analysis with good business foresight and regulatory understanding.

In his role at Esperer Bioresearch, Dhruv Arora will be responsible for strategizing and overseeing all export related activities for the companies Pharmaceutical & First time in the World to be a Patented Cancer-Nutrition Product formulation Technology. He will be based out of Mumbai and will report to the Founder & CEO, Raktim Chattopadhyay.

Dhruv’s previous stint comprises of M/S Vins Bi o Products Pvt. Ltd. Hyderabad, Bharat Serums & Vaccines Ltd, Mumbai and M/S Goldshield PLC. His competencies include identifying new markets operations for its Business Development activities. In his last assignment, at Vino Bins Products Ltd. he was the Vice President- Exports and was responsible for re-structuring marketing, regulatory & logistics and brought a strategic growth in sales for the company. He also gave outstanding performance for 7 Years as Country Manager Russia, Deputy General Manager Mena (Middle East & North Africa) & South East Asia, ROW (Rest of the World) Business Head.

“We are extremely pleased to welcome Dhruv as our Global Business Head. I am certa in that his diverse, comprehensive experience will provide significant confidence and provide tremendous benefit to our business. Dhruv’s appointment is imperative to our approach in discovering new growth avenues and providing a new dimension of our presence in the industry.” added Raktim Chattopadhyay, Founder & CEO Esperer Bioresearch.

Speaking on his appointment, Dhruv Arora said “It is a pleasure to be part of Esperer Bioresearch, offering me a compelling platform to build and nurture the business in this rapidly changing environment. I am looking forward to creating zestful w orking in organization, scaling the business to new heights.”

About Esperer Bioresearch:ESPERER stands for hope. And hope springs eternal in ESPERER as we step ahead in our endeavor to bring this hope in a scientific way to the patient, their family, their near and dear ones and the medical fraternity in general and the care giver and care acceptor in particular.For a Cancer patient, HOPE is everything. Hope is not easily defined, but impossible to embrace without faith. For in reality hope always signifies that something better will come out of it. ESPERER is focused on the very aspect of oncology: the medicine and molecules, the treatment and services during treatment, the help and support to the end user with a view of futuristic need for living a fulfilling life after being cured.